BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.
Pulm Circ
; 12(2): e12063, 2022 Apr.
Article
en En
| MEDLINE
| ID: mdl-35514770
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Pulm Circ
Año:
2022
Tipo del documento:
Article